The ongoing federal shutdown has abruptly cut off Medicare telehealth reimbursements, forcing hospitals and health systems to suspend remote care programs and significantly impacting care delivery models.

Tsinghua University debuts the world’s first AI hospital in China, transforming healthcare management and digital clinical training in Asia.

Fresenius Kabi’s Q3/2025 results reveal robust organic revenue and EBIT growth across Europe, with strategic investments planned in R&D for further market expansion in hospital pharmaceuticals and medical technologies.

Naples Community Hospital has become the first in the United States to implement advanced AI technology that can detect hidden cardiovascular risk markers up to ten years before a heart attack.

Perennial Holdings and Ruijin Hospital have formed a strategic partnership to develop an international medical services ecosystem and training platform in Shanghai, China.

bioMérieux announces strong Q3 2025 results and major laboratory diagnostic advancements, marking significant operational and technology upgrades for European healthcare facilities.

Atrium Health debuts the IRCAD North America surgical training center in Charlotte, rapidly attracting global medical professionals and positioning itself as a leader in high-tech surgical innovation and workforce development.

Johnson & Johnson MedTech presents new clinical and real-world data on pulsed field ablation for atrial fibrillation at a major Asia-Pacific cardiac conference.

Cosmo Pharmaceuticals has achieved CE certification for ColonPRO EU, bringing Europe its most advanced AI platform for colonoscopy, integrating detection, diagnosis, measurement, and quality monitoring in one real-time system.

Merck Foundation announces a $22 million national program supporting 11 organizations to advance equitable, high-quality cardiovascular care across underserved U.S. communities.